Frozen shoulder and menopause: what the evidence can—and cannot say

If a shoulder becomes painful and stiff around the menopause transition, is estrogen the explanation—or is that a pattern being mistaken for a cause? The fairest answer from the current evidence is narrower: frozen shoulder and menopause can appear in the same age range, connective-tissue biology offers a plausible hypothesis, and neither point proves why one person develops adhesive capsulitis.

Start with the association, not the conclusion

Frozen shoulder, also called adhesive capsulitis, is a condition marked by shoulder pain and progressive loss of movement. The 2022 clinical review describes a fibroproliferative process in the shoulder capsule involving collagen-producing cells, inflammation, and tissue changes that can make movement increasingly restricted.

The menopause connection is more limited than a headline can make it sound. A 2018 study of 197 perimenopausal and 113 premenopausal participants with shoulder arthralgia found adhesive capsulitis was the most common diagnosis in both groups, but the difference was not statistically significant. That is an observed result in a selected group of people who already had shoulder pain—not evidence that menopause caused frozen shoulder, or that menopause predicts it for an individual.

Association is not the same as causation

Several things can be true at once. Frozen shoulder often appears in midlife. The menopause transition also occurs in midlife. A study can find a pattern between a reproductive stage and a shoulder complaint. None of those facts, by themselves, identifies the causal pathway.

Age, activity, prior shoulder history, metabolic conditions, inflammatory processes, sleep, work demands, and the way symptoms are recognized can overlap with hormonal transition. These are potential confounders, not a complete explanation. The relevant question is not simply whether two events coexist; it is whether a study measured enough of the surrounding context to separate them.

A shared timeline can be a useful clue without becoming a causal claim.

Estrogen and connective tissue: a plausible mechanism, not proof

It is biologically plausible to ask whether changing estrogen exposure could influence connective tissue, inflammation, or the way a shoulder capsule remodels. The review’s description of collagen, fibroblasts, inflammation, and contracture gives that question a biological place to start.

But a mechanism is not an outcome. A plausible estrogen–connective-tissue pathway does not show that estrogen change caused a particular shoulder problem, that restoring a hormone level would change it, or that the pathway matters more than the other factors surrounding the condition. Mechanistic language should stay labeled as a hypothesis until human studies test the pathway directly.

What the 2026 pilot adds—and what it does not

A 2026 pilot study looked retrospectively at electronic records for 1,952 postmenopausal women aged 40–60 in one health maintenance organization. Adhesive capsulitis was recorded less often among women with hormone therapy use than among women without it, but the difference was not statistically significant.

That result is useful as a design signal, not a causal answer. The study was retrospective, came from one health system, and included a much smaller hormone-therapy group than the comparison group. The groups may also differ in ways the records did not fully capture. The authors describe the pilot as groundwork for larger prospective studies; it does not demonstrate a protective effect, establish an estrogen mechanism, or support an individual prediction.

Diagnosis and individual prediction remain unresolved

“Frozen shoulder” is not a label that can be assigned from age, menopause status, or pain location alone. The 2022 review notes that diagnosis relies heavily on physical examination and can be difficult depending on the stage of the condition or other shoulder pathology. That matters for the evidence question: if studies group different shoulder problems together, the apparent association can become harder to interpret.

The same caution applies in the other direction. A person can have shoulder stiffness during perimenopause without having adhesive capsulitis, and a person with adhesive capsulitis may have several relevant exposures at once. Population findings can describe patterns; they cannot tell one person what caused a symptom or forecast the next stage of an individual shoulder.

Keep the question open

The evidence supports a disciplined sentence: frozen shoulder and menopause overlap in a population where connective-tissue and inflammatory mechanisms are biologically interesting, but causation remains unresolved. The perimenopausal shoulder study does not show a significant adhesive-capsulitis difference, and the hormone-therapy pilot was retrospective and non-significant.

That is not a dead end. It is a better map. Read the Muscle & Bone source cards for the study populations, findings, and limitations, then return to Bone & Strength for the wider distinction between a scan, a symptom, function, and a personal story.